EUCTR2004-004386-15-IT进行中（未招募）不适用
An open-label, multicentre phase III scintigraphy study assessing 123I-mIBG uptake in subjects being evaluated for Pheochromocytoma and neuroblastoma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
An Open-Label, Multicentre, Phase 3 Scintigraphy Study Assessing 123I mIBG Uptake in Subjects Being Evaluated for Phaeochromocytoma or NeuroblastomaEUCTR2004-004386-15-DEGE Healthcare Limited and its affiliates230
进行中（未招募）
1 期
An Open-Label, Multicentre, Phase 3 Scintigraphy Study Assessing 123I mIBG Uptake in Subjects Being Evaluated for Phaeochromocytoma or NeuroblastomaPhaeochromocytoma and NeuroblastomaEUCTR2004-004386-15-GBGE Healthcare Limited and its affiliates255
尚未招募
3 期
An open label, randomised, muliticentre Phase III Trial of Dasatnib (SPRYCEL®) vs standard dose Imatininb (400mg) in the treatment of subjects with newly diagnosed chronic phase Philadelphia chromosome positive chronic myeloid leukaemia (CML).Chronic Myeloid Leukemia10024324NL-OMON31003Bristol-Myers Squibb5
进行中（未招募）
不适用
An open label, multi-centre, phase III, subject initiated safety study of ME-609 in treatment of recurrent herpes simplex labialis in adolescents.Herpes simplex labialisEUCTR2006-002828-42-SEMedivir AB300
未知
3 期
A multicenter, uncontrolled, open-label phase 3 trial of OPC-41061 in patients with hepatic edema - investigation of the safety of treatment at 7.5 mg beyond 7 days and of the effect of dose escalation to 15 mgCirrhosisJPRN-jRCT2080220951Otsuka Pharmaceutical Co., Ltd.50